US-Listed Public Company Profile built from SEC and market records · June 2026

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

$58.98 +1.65% NASDAQ: ARWR · 15-min delayed

PASADENA, California
Public · NASDAQ: ARWR
711 employees

Visit website Follow

$12.1BMarket cap

$829.4MRevenue · FY2025

-$1.6MNet income

711Employees

ARWRNASDAQ

1995IPO

About ARROWHEAD PHARMACEUTICALS, INC.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: ARWR
Employees: 711
IPO date: Feb 1, 1995
Headquarters: 177 E COLORADO BLVD
PASADENA, California 91105
Phone: 626-696-4702
Industry: Pharmaceuticals
Website: Visit site

Incorporation record

Incorporated in: DE, United States
Registered office: Camden, US
Legal entity ID: 549300O3CSB8T7OZ3D66

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Registry IDs

Ticker: ARWR Nasdaq
SEC CIK: 879407
LEI: 549300O3CSB8T7OZ3D66
EIN: 460408024
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Arrowhead Pharmaceuticals, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/arrowhead-pharmaceuticals-inc/"><img src="https://americancompanies.com/badge/arrowhead-pharmaceuticals-inc.svg" alt="Arrowhead Pharmaceuticals, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow ARROWHEAD PHARMACEUTICALS, INC. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $829.4M
Net income: -$1.6M
Total assets: $1.4B
Market cap: $12.1B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: ARWR

$58.98 +1.65%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$31.66 $89.59

52-week range

Market cap: $12.1B
Shares outstanding: 204.4M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Feb 1, 1995

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Price

Reported a net loss of $1.6M in FY2025.
Trading 34% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ARROWHEAD PHARMACEUTICALS, INC..

Write a review

Newsroom

News about ARROWHEAD PHARMACEUTICALS, INC.

AC Original Inside America's Pharmaceutical Industry: Who's Building It A look at eight verified American pharmaceutical companies, from Illinois biotech giants to California gene-therapy inn… Jul 10, 2026

AC Original Inside America's Pharmaceutical Industry: The Companies Behind the Medicine Cabinet A look at eight verified American pharmaceutical companies, where they're based, and why domestic drugmakers matter to … Jul 8, 2026

AC Original Pharmaceuticals in America: A Guide to Verified U.S. Drug Makers An overview of America's pharmaceutical industry and eight independently verified companies, from Illinois giants to Ca… Jul 7, 2026

AC Original Pharmaceuticals in America: The Companies Behind the Nation's Medicine Cabinet A look at the American pharmaceutical sector and eight independently verified companies, from Illinois giants to coasta… Jul 7, 2026

Homozygous Familial Hypercholesterolemia (HoFH) - 7MM Market, Epidemiology, and Forecast - 2036 | RNAi and Targeted Therapies Expand Uptake and Investment Opportunities GlobeNewswire Inc. · 2026-09-30 · positive Oligonucleotide CDMO Market to Reach USD 9.87 Billion by 2031 as RNA-Targeted Drug Pipelines Expand GlobeNewswire Inc. · 2026-07-15 · positive Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight GlobeNewswire Inc. · 2026-04-30 · positive IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight GlobeNewswire Inc. · 2026-04-29 · positive CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens Benzinga · 2026-02-13 · neutral Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight GlobeNewswire Inc. · 2026-02-09 · positive

News & sentiment via Polygon.io

FAQ

Arrowhead Pharmaceuticals, Inc.: frequently asked questions

Is Arrowhead Pharmaceuticals, Inc. an American company?

Yes — Arrowhead Pharmaceuticals, Inc. is an American company headquartered in Pasadena, California. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.

Where is Arrowhead Pharmaceuticals, Inc. headquartered?

Arrowhead Pharmaceuticals, Inc. is headquartered in Pasadena, California, United States.

Is Arrowhead Pharmaceuticals, Inc. publicly traded?

Yes — Arrowhead Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ARWR on the NASDAQ.

What does Arrowhead Pharmaceuticals, Inc. do?

Arrowhead Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore